Add Yahoo as a preferred source to see more of our stories on Google. A Moderna COVID-19 vaccine (brand name: Spikevax) photographed at Borinquen Health Care Center on May 29 in Miami. (Photo ...

Preliminary analysis showed the 2025-2026 formula of mNEXSPIKE generated greater than a 16-fold increase in LP.8.1-neutralizing antibodies across age groups Both of Moderna’s COVID-19 vaccines for the ...

Australia’s medicines regulator has confirmed it is evaluating a low dose for children as young as six-months-old.

Moderna Inc. (NASDAQ:MRNA) on Tuesday released preliminary immunogenicity data for the 2025-2026 formula of Spikevax, which targets the LP.8.1 variant of SARS-CoV-2 to help prevent COVID-19. The ...

Australia’s Therapeutic Goods Administration (TGA) has upgraded Moderna’s COVID-19 vaccine to full registration, making Spikevax the first COVID-19 vaccine to transition from provisional to full ...

Preliminary analysis showed the 2025-2026 formula of Spikevax generated greater than an 8-fold increase in LP.8.1-neutralizing antibodies across age groups Clinical findings reinforce preclinical data ...

The Food and Drug Administration announced new federal guidance for COVID-19 vaccinations on Wednesday that put new restrictions on how millions of Americans will be able to access the shots as ...